Top Markets
Coin of the day
Medigene AG Medigene AG

Medigene AG

MDG1
Hisse Senetlerindeki Sıralama #35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Hisse Fiyatı
$0.14942078
Son senkronizasyon: 2025-05-15
Piyasa Değeri
$3.86M
Değişim (1 gün)
0.10%
Değişim (1 yıl)
0.00%
Ülke
DE
Ticaret Medigene AG (MDG1)

Kategori

Medigene AG (MDG1) için gelir
Jun 2024 itibarıyla gelir TTM: $7.99M
Medigene AG şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) $7.99M'dir. 2022 yılında şirketin geliri $33.52M önceki yıla göre artış 2021 yılındaki $11.90M gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Medigene AG için 2004 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
Yıl Gelir Değiştir
2026 (TTM) $7.99M 19.85%
2023 $6.67M -80.10%
2022 $33.52M 181.71%
2021 $11.90M 22.09%
2020 $9.75M -17.36%
2019 $11.79M 35.46%
2018 $8.71M -5.48%
2017 $9.21M 113.45%
2016 $4.32M 28.15%
2015 $3.37M -77.88%
2014 $15.22M 46.65%
2013 $10.38M 34.07%
2012 $7.74M 160.02%
2011 $2.98M 0.59%
2010 $2.96M -94.55%
2009 $54.28M 16.25%
2008 $46.70M 44.83%
2007 $32.24M -19.79%
2006 $40.20M 73.97%
2005 $23.11M 36.31%
2004 $16.95M 0.00%
Benzer şirketler veya rakiplerin geliri
Şirket Gelir Gelir Farkı Ülke
$12.62B 157,814.80%
US
$6.02B 75,219.06%
NL
- -
CH
- -
KR
$10.11B 126,373.78%
BE